Bellano John 4

What Happened John Bellano, Chief Commercial Officer of MDxHealth SA (MDXH), received two option awards on June 1, 2026 totaling 333,000 options: 116,000 options and 217,000 options. The Form 4 reports these as derivative awards with $0 acquisition value. The options have an exercise (strike) price of $0.76 per ordinary share.

Key Details

• Transaction date: June 1, 2026; Form 4 filed June 3, 2026 (no indication of a late filing).
• Grant details: 116,000 options (Footnote F1) and 217,000 options (Footnote F2); combined = 333,000 options.
• Exercise price: $0.76 per share. If all options were exercised, the aggregate cash required would be $0.76 × 333,000 = $253,080.
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes:
  • F1: 116,000 options vest based on company performance criteria evaluated by the Board at the end of the relevant performance periods.
  • F2: 217,000 options vest in three equal installments on each of the first three anniversaries of the grant.
• Transaction type code: A = Award/Grant (derivative).

Context These were option awards (equity compensation) rather than open-market purchases or sales. Options give the holder the right to buy ordinary shares at $0.76 in the future if and when they vest and are exercised; until exercised, they are not underlying shares and do not represent immediate proceeds or sales. Such grants are typically used for retention and incentive purposes; they do not by themselves signal buying or selling of stock.